Opaldia, the UK's only independent service to provide genetic testing for breast cancer has welcomed the National Institute for Health and Clinical Excellence report today that women below the age of 50 with a family history of the disease should have yearly MRI scans.
James Mackay, Opaldia's Medical Director, said that while this was a step forward, more could also be done through genetic testing.
"The advances in genetic testing mean that we can now give an accurate assessment of how likely it may be that a woman below 50 may get breast cancer. We can identify individuals at higher risk and then provide the necessary support to them."
